CFSAN Examines AER Reporting Following Bitter Orange Miscalculation
This article was originally published in The Tan Sheet
FDA's Center for Food Safety & Applied Nutrition is in the process of making corrections to its adverse event reporting procedures for bitter orange following a miscalculation of the number of AERs tied to the ingredient
You may also be interested in...
FDA Commissioner Mark McClellan, MD/PhD, said the "framework" for the outright ban of ephedra will be based on substantive scientific evidence as the agency prepares to publish the reg
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning